Kazia Therapeutics Ltd ADR (KZIA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | KZIA | AMGN | GILD | BMY | VRTX |
| Company | Kazia Therapeutics Ltd ADR | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NYSE | NASDAQ |
| Open | 1.7700 | 263.14 | 92.62 | 56.97 | 403.14 |
| High | 1.8400 | 263.27 | 92.80 | 57.12 | 406.72 |
| Low | 1.7700 | 261.28 | 92.30 | 56.78 | 402.72 |
| Last | 1.8395 | 262.91 | 92.27 | 56.80 | 408.22 |
| Change | +0.0695 | +2.27 | -0.10 | +0.24 | +5.52 |
| % Change | +3.93% | +0.87% | -0.11% | +0.42% | +1.37% |
| Volume | 56,048 | 188,123 | 29,481 | 529,879 | 58,755 |
| 20-Day Average Volume | 114,612 | 3,649,501 | 6,625,814 | 10,835,974 | 1,824,149 |
| Previous Close | 1.7700 | 260.64 | 92.37 | 56.56 | 402.70 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 3.2937 | 267.47 | 92.43 | 57.34 | 437.22 |
| 20-Day Raw Stochastic | 2.69% | 35.06% | 59.96% | 41.53% | 27.98% |
| 20-Day Relative Strength | 29.67% | 34.65% | 53.04% | 50.88% | 35.27% |
| Weighted Alpha | -83.31 | -18.09 | +20.62 | +16.66 | -10.02 |
| Today's Opinion | 40% Sell | 88% Sell | 100% Buy | 72% Buy | 72% Sell |
| Previous Opinion | 40% Sell | 88% Sell | 88% Buy | 56% Buy | 72% Sell |
| Last Month's Opinion | 80% Buy | 72% Sell | 100% Buy | 100% Buy | 8% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -36.79% since 12/24/24 | -0.69% since 12/24/24 | -1.60% since 12/24/24 | -1.32% since 12/24/24 | -0.67% since 12/24/24 |
| Low | 1.7500 on 12/31/24 | 258.50 on 12/30/24 | 91.72 on 12/30/24 | 55.93 on 12/31/24 | 399.06 on 12/30/24 |
| High | 3.2000 on 12/26/24 | 264.73 on 12/26/24 | 94.55 on 12/26/24 | 58.38 on 12/27/24 | 411.29 on 12/26/24 |
| 1-Month | |||||
| %Chg | -63.21% since 12/02/24 | -5.55% since 12/02/24 | -1.67% since 12/02/24 | -4.90% since 12/02/24 | -12.94% since 12/02/24 |
| Low | 1.7500 on 12/31/24 | 253.30 on 12/19/24 | 89.15 on 12/13/24 | 55.04 on 12/13/24 | 377.85 on 12/19/24 |
| High | 5.2000 on 12/03/24 | 281.38 on 12/03/24 | 94.65 on 12/11/24 | 60.09 on 12/03/24 | 476.46 on 12/10/24 |
| 3-Month | |||||
| %Chg | -57.85% since 10/02/24 | -17.85% since 10/02/24 | +9.10% since 10/02/24 | +6.03% since 10/02/24 | -12.27% since 10/02/24 |
| Low | 1.7500 on 12/31/24 | 253.30 on 12/19/24 | 83.98 on 10/04/24 | 51.31 on 10/15/24 | 377.85 on 12/19/24 |
| High | 7.8100 on 11/04/24 | 329.17 on 10/11/24 | 98.90 on 11/11/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 |
| 6-Month | |||||
| %Chg | -14.16% since 07/02/24 | -15.48% since 07/02/24 | +35.16% since 07/02/24 | +40.91% since 07/02/24 | -14.42% since 07/02/24 |
| Low | 1.7500 on 12/31/24 | 253.30 on 12/19/24 | 66.01 on 07/05/24 | 39.35 on 07/05/24 | 377.85 on 12/19/24 |
| High | 15.8000 on 07/11/24 | 346.85 on 07/25/24 | 98.90 on 11/11/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 7,708 | 140,102,608 | 115,117,592 | 114,713,688 | 103,706,928 |
| Shares Outstanding, K | 4,355 | 537,533 | 1,246,266 | 2,028,177 | 257,529 |
| Annual Sales | 1,630,000 | 28,190,000,000 | 27,116,000,000 | 45,006,000,000 | 9,869,200,000 |
| Annual Net Income | -17,560,000 | 6,717,000,000 | 5,665,000,000 | 8,025,000,000 | 3,619,600,000 |
| Last Quarter Sales | 2,897,743 | 8,503,000,000 | 7,545,000,000 | 11,892,000,000 | 2,771,900,000 |
| Last Quarter Net Income | -4,369,673 | 2,830,000,000 | 1,253,000,000 | 1,211,000,000 | 1,045,400,000 |
| 60-Month Beta | 1.98 | 0.55 | 0.18 | 0.45 | 0.36 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 5.58 on 10/30/24 | 2.02 on 11/06/24 | 1.80 on 10/31/24 | 4.38 on 11/04/24 |
| Latest Earnings Date | 02/21/25 | 02/04/25 | 02/11/25 | 02/06/25 | 02/03/25 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | 0.770 on 12/13/24 | 0.620 on 01/03/25 | N/A |
| Next Ex-Dividends Date | N/A | 02/14/25 | 12/13/24 | 01/03/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 13.49 | 20.77 | 47.91 | 0.00 |